| Literature DB >> 28052859 |
Philip W Brummond1, David F Chen2, William W Churchill3, John S Clark4, Kevin R Dillon5, Doina Dumitru6, Lynn Eschenbacher7, Toni Fera8, Christopher R Fortier9, Kristine K Gullickson10, Kristen Jurakovich11, Stan Kent12, Jennifer Keonavong13, Christine Marchese14, Tricia Meyer15, Lee B Murdaugh16, Richard K Ogden17, Brian C O'Neal18, Steve Rough11, Rafael Saenz19, Jacob S Smith20.
Abstract
Keywords: controlled substances; documentation; facility regulation and control; patient safety; prescription drug diversion; quality improvement
Mesh:
Substances:
Year: 2017 PMID: 28052859 DOI: 10.2146/ajhp160919
Source DB: PubMed Journal: Am J Health Syst Pharm ISSN: 1079-2082 Impact factor: 2.637